<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pulmonary/Respiratory Medicine &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pulmonary-respiratory-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jul 2021 04:38:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Pulmonary/Respiratory Medicine &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Goal-setting and positive parent-child relationships reduce risk of youth vaping</title>
		<link>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/</link>
					<comments>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jul 2021 04:38:07 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Addiction]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Health Professionals]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/</guid>

					<description><![CDATA[Credit: UPMC PITTSBURGH, July 26, 2021 &#8211; Adolescents who set goals for their future and those with strong parental support are less likely to use e-cigarettes and other tobacco products, according to a study by UPMC Children&#8217;s Hospital of Pittsburgh and University of Pittsburgh School of Medicine physician-scientists. The research, published today in the journal [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/goal-setting-and-positive-parent-child-relationships-reduce-risk-of-youth-vaping/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174520</post-id>	</item>
		<item>
		<title>Advantages of intranasal vaccination against SARS-CoV-2</title>
		<link>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</link>
					<comments>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 17:40:38 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/</guid>

					<description><![CDATA[Intranasal vaccination is needle-free and elicits immunity at the site of infection, the respiratory tract Credit: UAB BIRMINGHAM, Ala. &#8211; There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/advantages-of-intranasal-vaccination-against-sars-cov-2/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174491</post-id>	</item>
		<item>
		<title>Featured articles from the journal CHEST®, July 2021</title>
		<link>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/</link>
					<comments>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:38:06 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Critical Care/Emergency Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Sleep/Sleep Disorders]]></category>
		<guid isPermaLink="false">https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/</guid>

					<description><![CDATA[Credit: González Gutiérrez J., et al, Journal CHEST® Glenview, Ill. &#8211; Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care, sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonology and cardiology, sleep, and thoracic oncology. [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/featured-articles-from-the-journal-chest-july-2021/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174479</post-id>	</item>
		<item>
		<title>Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested</title>
		<link>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/</link>
					<comments>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jul 2021 18:58:03 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Mathematics/Statistics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/</guid>

					<description><![CDATA[Analysis suggests same epidemiological outcomes possible with rapid-antigen versus RT-PCR tests Credit: Philip Cherian, Sandeep Krishna and Gautam Menon, 2021, PLOS Computational Biology A computational analysis of COVID-19 tests suggests that, in order to minimize the number of infections in a population, the amount of testing matters more than the sensitivity of the tests that [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174408</post-id>	</item>
		<item>
		<title>FDA approves Octapharma&#8217;s Octagam® 10% for adult dermatomyositis</title>
		<link>https://bioengineer.org/fda-approves-octapharmas-octagam-10-for-adult-dermatomyositis/</link>
					<comments>https://bioengineer.org/fda-approves-octapharmas-octagam-10-for-adult-dermatomyositis/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 17:40:09 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Critical Care/Emergency Medicine]]></category>
		<category><![CDATA[Dermatology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Orthopedic Medicine]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fda-approves-octapharmas-octagam-10-for-adult-dermatomyositis/</guid>

					<description><![CDATA[FDA approval based on positive results of international, multi-center ProDERM study Credit: Octapharma PARAMUS, N.J. &#8211; The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis, a rare immune-mediated [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/fda-approves-octapharmas-octagam-10-for-adult-dermatomyositis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174164</post-id>	</item>
		<item>
		<title>A breath of fresh air for emphysema research</title>
		<link>https://bioengineer.org/a-breath-of-fresh-air-for-emphysema-research/</link>
					<comments>https://bioengineer.org/a-breath-of-fresh-air-for-emphysema-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 16:34:19 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<category><![CDATA[Mortality/Longevity]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/a-breath-of-fresh-air-for-emphysema-research/</guid>

					<description><![CDATA[Credit: Department of Immune Regulation,TMDU Tokyo, Japan &#8211; Chronic obstructive pulmonary disease (COPD) causes illness and death worldwide. It is characterized by destruction of the walls of tiny air sacs in the lungs, known as emphysema, and a decline in lung function. Little has been known about the mechanisms by which it begins to develop. [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/a-breath-of-fresh-air-for-emphysema-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174060</post-id>	</item>
		<item>
		<title>Firefighters found to have persistent lung damage from Fort McMurray wildfire</title>
		<link>https://bioengineer.org/firefighters-found-to-have-persistent-lung-damage-from-fort-mcmurray-wildfire/</link>
					<comments>https://bioengineer.org/firefighters-found-to-have-persistent-lung-damage-from-fort-mcmurray-wildfire/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 16:08:56 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Environmental Health]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/firefighters-found-to-have-persistent-lung-damage-from-fort-mcmurray-wildfire/</guid>

					<description><![CDATA[Risk of developing asthma is more than doubled, says University of Alberta occupational health researcher who used the same parameters as a study on 9-11 first responders. Credit: Richard Siemens (Edmonton, AB) Firefighters at the centre of the battle against the massive Fort McMurray wildfire in 2016 have persistent lung damage, according to new findings [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/firefighters-found-to-have-persistent-lung-damage-from-fort-mcmurray-wildfire/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174050</post-id>	</item>
		<item>
		<title>A small molecule induces readthrough of cystic fibrosis CFTR nonsense mutations</title>
		<link>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/</link>
					<comments>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 15:50:35 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/</guid>

					<description><![CDATA[This research suggests that a path to treat currently untreatable cases of cystic fibrosis is clearly achievable. Credit: UAB BIRMINGHAM, Ala. &#8211; An experimental drug reported in Nature Communications suggests that a &#8220;path is clearly achievable&#8221; to treat currently untreatable cases of cystic fibrosis disease caused by nonsense mutations. This includes about 11 percent of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/a-small-molecule-induces-readthrough-of-cystic-fibrosis-cftr-nonsense-mutations/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174035</post-id>	</item>
		<item>
		<title>Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development</title>
		<link>https://bioengineer.org/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/</link>
					<comments>https://bioengineer.org/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Jul 2021 15:43:33 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medical/Scientific Ethics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/</guid>

					<description><![CDATA[The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research &#038; Development Consortium Credit: UNITE4TB To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/launch-of-unite4tb-partnership-marks-a-new-era-in-tuberculosis-treatment-development/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173853</post-id>	</item>
		<item>
		<title>The cells combating a deadly lung disease</title>
		<link>https://bioengineer.org/the-cells-combating-a-deadly-lung-disease/</link>
					<comments>https://bioengineer.org/the-cells-combating-a-deadly-lung-disease/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 15 Jul 2021 13:50:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Developmental/Reproductive Biology]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Molecular Biology]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/the-cells-combating-a-deadly-lung-disease/</guid>

					<description><![CDATA[A subset of fibroblasts located in small foci of tissue on the edges of extensive scarring produce a protein that protects against cell aging. Credit: Nakahara Y, Hashimoto N, Sakamoto K, et al. ERJ 2021 Single-cell RNA sequencing has revealed a subset of cells that could provide protection from a rare, but severely debilitating and [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/the-cells-combating-a-deadly-lung-disease/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173825</post-id>	</item>
		<item>
		<title>Scientists identify new gut-liver drug recycling process</title>
		<link>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/</link>
					<comments>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jul 2021 17:22:10 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Liver]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Metabolism/Metabolic Diseases]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<category><![CDATA[Pharmaceutical Sciences]]></category>
		<category><![CDATA[Pharmaceutical/Combinatorial Chemistry]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/</guid>

					<description><![CDATA[Implications for developing treatments for intestinal diseases Credit: University of Houston A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines &#8211; followed by recycling through the liver &#8211; that could have important implications for developing treatments for intestinal diseases and for taking multiple medications [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/scientists-identify-new-gut-liver-drug-recycling-process/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173789</post-id>	</item>
		<item>
		<title>Short chain fatty acids: An &#8216;ace in the hole&#8217; against SARS-CoV-2 infection</title>
		<link>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/</link>
					<comments>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/#comments</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jul 2021 16:01:55 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/</guid>

					<description><![CDATA[Scientists find that short chain fatty acids can be used to reduce susceptibility to SARS-CoV-2 infection and mortality from COVID-19 Credit: Kanako Yoshida from University of Fukui Humans are no stranger to coronavirus (CoV) pandemics. Just like SARS-CoV-2 (the virus that causes COVID-19), another member of the coronavirus family&#8211;SARS-CoV&#8211;caused the severe acute respiratory syndrome (SARS) [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173765</post-id>	</item>
		<item>
		<title>Allocating COVID-19 vaccines based on health and socioeconomics could reduce mortality</title>
		<link>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</link>
					<comments>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 19:00:02 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</guid>

					<description><![CDATA[Study suggests spatial relationship between COVID-19 mortality and population-level health factors Credit: Kandula S and Shaman J, 2021, PLOS Medicine COVID-19 vaccination strategies in the United States are informed by individual characteristics such as age and occupation. A study published in the open access journal PLOS Medicine by Sasikiran Kandula and Jeffrey Shaman of Columbia [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173677</post-id>	</item>
		<item>
		<title>COVID-19 ARDS focus of latest ATS/CSL Behring research grant recipient</title>
		<link>https://bioengineer.org/covid-19-ards-focus-of-latest-ats-csl-behring-research-grant-recipient/</link>
					<comments>https://bioengineer.org/covid-19-ards-focus-of-latest-ats-csl-behring-research-grant-recipient/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 13:35:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Critical Care/Emergency Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/covid-19-ards-focus-of-latest-ats-csl-behring-research-grant-recipient/</guid>

					<description><![CDATA[Credit: ATS New York, NY &#8211; July 13, 2021- The ATS Research Program is pleased to announce that William Zhang, MD, of Weill Cornell Medical Center is the recipient of the 2020-2021 ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome. The $50,000 award will support Dr. Zhang&#8217;s research study, &#8220;Hyperferritinemia in COVID-19 ARDS: Friend [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/covid-19-ards-focus-of-latest-ats-csl-behring-research-grant-recipient/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173585</post-id>	</item>
		<item>
		<title>Dr. Anthony Shum receives ATS Research Program/chILD Foundation Partner grant</title>
		<link>https://bioengineer.org/dr-anthony-shum-receives-ats-research-program-child-foundation-partner-grant/</link>
					<comments>https://bioengineer.org/dr-anthony-shum-receives-ats-research-program-child-foundation-partner-grant/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jul 2021 13:38:07 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Researchers/Scientists/Awards]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dr-anthony-shum-receives-ats-research-program-child-foundation-partner-grant/</guid>

					<description><![CDATA[Credit: ATS (July 12, 2021) &#8212; The ATS Research Program and the chILD Foundation have awarded Anthony Shum, MD, of the University of California, San Francisco $80,000. The award will support Dr. Shum&#8217;s research project, &#8220;Defining the pathogenesis of childhood ILD in COPA syndrome.&#8221; The ATS Research Program Partner Grants provide crucial support to talented [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/dr-anthony-shum-receives-ats-research-program-child-foundation-partner-grant/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173497</post-id>	</item>
		<item>
		<title>The incidence of COVID-19 in a Brazilian regional soccer league is one of the highest</title>
		<link>https://bioengineer.org/the-incidence-of-covid-19-in-a-brazilian-regional-soccer-league-is-one-of-the-highest/</link>
					<comments>https://bioengineer.org/the-incidence-of-covid-19-in-a-brazilian-regional-soccer-league-is-one-of-the-highest/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jul 2021 15:38:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<category><![CDATA[Sports Medicine]]></category>
		<category><![CDATA[Sports/Recreation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/the-incidence-of-covid-19-in-a-brazilian-regional-soccer-league-is-one-of-the-highest/</guid>

					<description><![CDATA[Researchers analyzed almost 30,000 RT-PCR tests on swabs from 4,269 players in 2020: 11.7% turned out positive; the rate was the same as among front-line health workers Credit: Bruno Gualano By Karina Toledo &#124; Agência FAPESP* – A study conducted at the University of São Paulo (USP) in Brazil shows that the incidence of infections [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/the-incidence-of-covid-19-in-a-brazilian-regional-soccer-league-is-one-of-the-highest/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173461</post-id>	</item>
		<item>
		<title>Reduced vs. standard CT dose for lung nodules in children, young adults with cancer</title>
		<link>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/</link>
					<comments>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 09 Jul 2021 14:24:59 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/</guid>

					<description><![CDATA[Reduced-dose CT depicts greater than 90% of lung nodules in children and young adults with cancer, identifying the presence of nodules with moderate sensitivity and high specificity Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR) Leesburg, VA, July 9, 2021&#8211;According to ARRS&#8217; American Journal of Roentgenology (AJR), reduced-dose CT depicts greater than [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/reduced-vs-standard-ct-dose-for-lung-nodules-in-children-young-adults-with-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173437</post-id>	</item>
		<item>
		<title>Dr. Jessica Blackburn awarded ATS/GSK research grant in obstructive lung disease</title>
		<link>https://bioengineer.org/dr-jessica-blackburn-awarded-ats-gsk-research-grant-in-obstructive-lung-disease/</link>
					<comments>https://bioengineer.org/dr-jessica-blackburn-awarded-ats-gsk-research-grant-in-obstructive-lung-disease/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 12:33:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Researchers/Scientists/Awards]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dr-jessica-blackburn-awarded-ats-gsk-research-grant-in-obstructive-lung-disease/</guid>

					<description><![CDATA[Credit: ATS July 08, 2021 &#8211; Today, the ATS Research Program announced that Jessica Blackburn, PhD, of Vanderbilt University has been awarded the ATS/GSK Research Grant in Obstructive Lung Disease. The grant was funded through GlaxoSmithKline (GSK) support of the ATS Research Program. The $100,000 award will support Dr. Blackburn&#8217;s study, &#8220;The Role of YAP/TAZ [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/dr-jessica-blackburn-awarded-ats-gsk-research-grant-in-obstructive-lung-disease/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173313</post-id>	</item>
		<item>
		<title>Children&#8217;s Hospital Colorado one of 7 US children&#8217;s hospitals driving asthma research</title>
		<link>https://bioengineer.org/childrens-hospital-colorado-one-of-7-us-childrens-hospitals-driving-asthma-research/</link>
					<comments>https://bioengineer.org/childrens-hospital-colorado-one-of-7-us-childrens-hospitals-driving-asthma-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jul 2021 14:44:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/childrens-hospital-colorado-one-of-7-us-childrens-hospitals-driving-asthma-research/</guid>

					<description><![CDATA[NIH awards $2.3 million to Colorado to support first long-term pediatric asthma study in emergency department patients experiencing asthma symptoms Credit: Children&#8217;s Hospital Colorado AURORA, Colo. (July 7, 2021) &#8211; Children&#8217;s Hospital Colorado (Children&#8217;s Colorado) is one of seven pediatric hospitals joining Childhood Asthma in Urban Settings (CAUSE), a clinical research network established by the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/childrens-hospital-colorado-one-of-7-us-childrens-hospitals-driving-asthma-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173222</post-id>	</item>
		<item>
		<title>Novel coronavirus infects and replicates in salivary gland cells</title>
		<link>https://bioengineer.org/novel-coronavirus-infects-and-replicates-in-salivary-gland-cells/</link>
					<comments>https://bioengineer.org/novel-coronavirus-infects-and-replicates-in-salivary-gland-cells/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 06 Jul 2021 19:46:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Dentistry/Periodontal Disease]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Physiology]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/novel-coronavirus-infects-and-replicates-in-salivary-gland-cells/</guid>

					<description><![CDATA[A study conducted at the University of São Paulo suggests that tissues specializing in saliva production and secretion serve as reservoirs for SARS-CoV-2, magnifying its infectious potential. Credit: Bruno Matuck/USP In Brazil, researchers at the University of São Paulo’s Medical School (FM-USP) have discovered that SARS-CoV-2 infects and replicates in the salivary glands. Analysis of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/novel-coronavirus-infects-and-replicates-in-salivary-gland-cells/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173167</post-id>	</item>
	</channel>
</rss>
